Group items tagged

The last 2 decades have witnessed an increased use of digital devices due to major advancements in information technology. These advancements have harmed adversely, the most important buddy in our body - The Eye. Devices like desktop and laptop computers, televisions, e-readers, smartphones, tablets, gaming gadgets have impacted our eyes massively which causes digital eye strain. This is a temporary discomfort to eyes that generally follow 2 or more hours of digital device use as people tend to switch between such devices repeatedly or use one for longer periods. Signs of Digital Eye Strain? 1.) Headaches 2.) Eye fatigue 3.) Irritated, dry, or red eyes 4.) Neck, shoulder, and back pain 5.) Blurred vision To know the prevention and treatment methods for Digital eye strain visit the blog

ACL Digital is Your Preferred Partner for Semiconductor Solutions in the USA Embedded systems and semiconductor technology have converged, reshaping our interactions with the world. Continuous innovation in the semiconductor industry is driving technological breakthroughs, creating a more innovative, highly connected world. ACL Digital provides high-performance, cost-effective, and reliable hardware and software solutions for OEMs and enterprises. Comprehensive Semiconductor Services in the USA ACL Digital empowers your chip design journey with a full spectrum of services, including VLSI IPs, ASICs, SoCs, and FPGAs. From architecture to RTL design, verification, and GDSII, our engineering team is at the forefront of innovation. We focus on low-power, high-speed, and area-efficient designs to deliver advanced solutions globally. Key Highlights of Our Semiconductor Practice * In-House Capabilities We build next-generation semiconductor solutions in the USA, from initial chip design to cutting-edge silicon and embedded software. * Seamless Integration Our design and test engineering processes enable optimized costs and maximized performance. * End-to-End Services We offer chip design, verification, IP integration, and embedded software solutions, ensuring the highest ROI on R&D investments. ACL Digital's Semiconductor Offerings * VLSI Design and Engineering Advanced VLSI solutions and engineering expertise, from RTL design and architecture to FIP. * Silicon Embedded Engineering Comprehensive services from pre-silicon to post-silicon validation, solution engineering, pro-support/IDH, and more. Why Choose ACL Digital * Expert in Semiconductor Solutions We lead in design-led semiconductor engineering, product engineering, and digital experience services. * Strong Technology Partnerships Collaborations with NXP, Marvell, Texas Instruments, Silicon Labs, ARM, and others provide full development cycle support. * Technological Advancements Market readiness

On Independence day 2020, The government of India has launched the National Digital Health Mission to digitize the health records of citizens/patients. With this digitization, the patient will now no longer be worried to take with him/her the health records while visiting the doctor for their health issues as everything would be available online, anytime and anywhere.

The solution innovation team at ACL Digital Life Sciences works with biotechnology, pharmaceuticals, medical device companies, and CRO to understand the day-to-day challenges, cost optimization goals, the need for aggressive digital transformation, and a staggering pace of healthcare evolution.

The convergence of digital engineering and automation solutions has emerged as a pivotal force, reshaping traditional processes, and driving unprecedented advancements in the life sciences industry. Adopting intelligent automation, which combines AI and robotic process automation, has significantly impacted various sectors. Yet, its integration in healthcare and life sciences has been relatively slow until recent years. https://www.acldigital.com/blogs/leveraging-digital-engineering-impact-automation-solutions-life-sciences-industry

Apple has joined forces with Eli Lilly and Evidation Health on a new feasibility study to detect evidence of brain decline with data from personal digital devices. The research has revealed that these devices may help in the identification of mild cognitive impairment (MCI) and Alzheimer's disease dementia.

Digital health interventions (DHIs) are fast emerging as vital tools to promote personal health and provide essential services. DHIs can be accessed through mobile phones, tablets and computers, as well as serve as effective support systems to improve personal health.

National Digital Health Mission​, this ambitious mission is a move forward in strengthening the Indian health infrastructure lacking patient records and health. The government's proposal, now put up for public review, focuses on necessary data privacy measures that need to be put in place in order to safeguard the confidentiality of sensitive health information of citizens. Announced by the Prime Minister, the mission aims to "voluntarily" give every Indian citizen a unique health ID which will serve as a digital repository containing all their health data as well as provide an ​enrolment of​ doctors and health facilities. For more details read the blog completely

This blog speaks of how social media can affect people and how a detox ones in a while helps with maintaining a healthy balance with reality.

This blog speaks of how social media can affect people and how a detox ones in a while helps with maintaining a healthy balance with reality.

At ACL Digital Life Sciences, our clinical data managers are well-experienced in hosting EDCs or providing vendor oversight. Our clinical data managers have years of experience in multiple therapeutic areas across all Phase I-IV studies. We are highly qualified in CDISC compliance and SME-level expertise to produce results with the speed and accuracy you need.

ACL Digital Life Sciences has one of the largest pools of qualified resources in multiple functional areas who are adequately positioned to deliver comprehensive state-of-the art Services and Solutions across the entire Life Sciences domain.

Today's world is witnessing a growing trend toward digitization, connectivity, and automation. However, the driving force behind this transformation, which is often overlooked, is embedded systems technology.

Artificial Intelligence Market by Technology (Deep Learning, Robotics, Digital Personal Assistant, Querying Method, Natural Language Processing, Context Aware Processing), Offering, End-User Industry, and Geography - Global Forecast to 2022

Fraunhofer Institute for Digital Medicine MEVIS in Germany has developed a new catheter system called Intelligent Catheter Navigation (IntelliCath) to enable precise navigation through the vasculature.

The Healthcare Industry is digitally transforming with Healthcare Mobile Device Management Solutions. Know the significant 5 ways how MDM Solution is driving mobility and redefining healthcare services.

UK-based online therapy provider Ieso Digital Health has applied deep learning to provide new insights into which aspects of psychotherapy are the most effective.

MedRhythms, a US-based digital therapeutics company, has launched its five-site randomised controlled trial (RCT) at rehabilitation hospitals and research centres to examine a post-stroke walking rehabilitation device.

Global drug discovery services market will continue to grow, owing to upsurge in externalization of R&D activities, rising expenditure on R&D, and increasing incidence of chronic diseases. Expiration of patents boosting the demand for drug discovery and the introduction of innovative drug discovery technologies are projected to support the market growth during the forecast period 2019-2025. The global drug discovery services market, by type, is segmented into medicinal chemistry services, biology services, and pharmacokinetics and drug metabolism. Among these, the medicinal chemistry services segment accounted for the largest share in 2018 and is expected to grow at a high-double-digit CAGR by 2025. Increasing tendency of pharma companies to externalize discovery & development services, upsurge in the number of drug discovery & development activities, and growing R&D expenditure are the key factors driving the growth of the segment.

The global market for chronic kidney disease drugs is expected to witness single-digit growth during 2019-2025. The drug pipeline of chronic kidney disease looks promising with novel therapeutic approaches, such as cell therapy, likely to enhance the market growth opportunities. However, the competition from biosimilars and complex drug development processes are impeding the market growth. Over the period, extensive research is being done to fill the unmet needs' gap. The advances in the arena of regenerative treatment have come up with budding advancement of cell therapies that help regeneration and repairing of the kidneys. Cell therapy is proficient of refining the fundamental functioning capability of the kidney. Uncontrolled high blood pressure and diabetes are the leading causes of kidney failure globally.